Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany.

Subjects

Subjects :

Humans
United States
Switzerland
Canada
Germany
Health Services Accessibility
Anti-Obesity Agents therapeutic use
Obesity drug therapy
Weight Loss drug effects
Glucagon-Like Peptide 1 agonists

Details

Language :

English

ISSN :

2168-6114

Volume :

184

Issue :

9

Database :

MEDLINE

Journal :

JAMA internal medicine

Publication Type :

Academic Journal

Accession number :

39008326

Full Text :

https://doi.org/10.1001/jamainternmed.2024.2559